Insulin is not optional for those who are managing diabetes. Prices have been going up, causing hardship for those who depend on the medicine to survive.
Michigan’s Attorney General Dana Nessel has launched an investigation into the Eli Lilly pharmaceutical company, invoking the Michigan Consumer Protection Act to target “grossly excessive prices”, according to a release from Nessel’s office.
Part of the action is a reconsideration of two Michigan Supreme Court rulings that limit the use of the Consumer Protection Act. A change to the rulings will allow Nessel to devote the Consumer Oversight Division to the investigation.
In explaining the action, Nessel said, “The average out-of-pocket cost of a single vial of insulin is nearing $100. No Michigander should have to face that kind of cost for life-saving medicine. While drug companies profit off of people’s health, they also benefit from a current market in which they control the pricing. Enough is enough.”
Several bills are currently making their way through the legislature that would cap the cost of insulin at $50 per month per user.
Reporting for WGRT – Jennie McClelland
